One notable example for HNSCC involves the development of a PROTAC, TSM-1, designed based on a natural small molecule toosendanin (TSN), to degrade STAT3, a protein often implicated in the progression of epithelial cancers, including HNSCC. This evidence concerns the gene TSN and head and neck squamous cell carcinoma.